Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.4%

2 terminated/withdrawn out of 27 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

0 of 12 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

8(66.7%)

Phase 3

3(25.0%)

Phase 2

1(8.3%)

12Total

N/A(8)

Phase 3(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT06931938Not ApplicableRecruiting

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

Role: collaborator

NCT05884866Phase 2Completed

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Role: lead

NCT06754137Not ApplicableRecruiting

Assessing AI-Supported Fracture Detection in Emergency Care Units

Role: collaborator

NCT07052045Not ApplicableRecruiting

One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy

Role: collaborator

NCT07137260Recruiting

Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial

Role: collaborator

NCT06929468Not Yet Recruiting

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer